Biocompatibility and in vivo tolerability of a new class of photoresponsive alkoxylphenacyl‐based polycarbonates. Issue 5 (25th March 2013)

• Record Type: Journal Article
• Authors: Wehrung, Daniel; Sun, Shuangyi; Chamsaz, Elaheh A.; Joy, Abraham; Oyewumi, Moses O.
• Is Part Of: Journal of pharmaceutical sciences. Volume 102:Issue 5(2013:May)
• Page Start: 1650
• Page End: 1660
• Publication Date: 2013-03-25
• Subjects: biocompatibility -- alkoxylphenacyl -- polycarbonates -- photoresponsive -- implants -- toxicity; Pharmacy -- Periodicals; 615.1
• DOI: 10.1002/jps.23510
• Languages: English
• ISSNs: 0022-3549

Abstract

Abstract: Potential toxicities of chromophoric or polymeric units of most photoresponsive delivery systems have impacted clinical relevance. Herein, we evaluated the biocompatibility and tolerability of alkoxylphenacyl‐based polycarbonates (APPs) as a new class of photoresponsive polymers. The polymers were applied as homopolymer or copolymers of polyethylene glycol (10%, w/w) or polycaprolactone (10%, w/w). APP polymers were comparable to poly(lactic‐co‐glycolic acid) (PLGA) based on cytotoxicity, macrophage activation, and blood compatibility. Data from biodistribution studies in BALB/c mice showed preferential accumulation in kidney and liver. Meanwhile, potential application of APP polymers as immediate or sustained (implants) drug delivery systems indicated that liver and kidney functions were not distorted. Also, plasma levels of tumor necrosis factor‐alpha and interleukin‐6 were comparable to PLGA‐treated mice ( p > 0.05). A histological analysis of liver and kidney sections showed no detectable damage for APP polymers. The overall data strongly supported potential consideration of APP polymers as photoresponsive delivery systems especially as implantable or tissue‐mimicking photopatterned biomaterials. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:1650–1660, 2013